[Biphasic effect of phenylalanine- lysine-vasopressin on the lower esophageal sphincter and its significance in the treatment of hemorrhages from esophageal varices].
D000328:Adult; D004932:Esophageal and Gastric Varices / Q000150:complications*; D004943:Esophagogastric Junction / Q000187:drug effects*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008236:Lypressin / Q000627:therapeutic use*; D008297:Male; D010649:Phenylalanine; D014667:Vasopressins / Q000031:analogs & derivatives*
D014667:Vasopressins; D010649:Phenylalanine; D008236:Lypressin
Biphasische Wirkung von Phenylalanin-Lysin-Vasopressin auf den unteren Osophagussphinkter und ihre Bedeutung für die Behandlung von Osophagusvarizenblutungen.